Document is current
Any future updates will be listed below
-
Authors
Schmitt, Lauren M.
Smith, Elizabeth G.
Pedapati, Ernest V.
Horn, Paul S.
Will, Meredith
Lamy, Martine
Barber, Lillian
Trebley, Joe
Meyer, Kevin
Heiman, Mark
West, Korbin H. J.
Hughes, Phoevos
Ahuja, Sanjeev
Erickson, Craig A.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04944901 at ClinicalTrials.govDocuments that mention this clinical trial
Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder
https://doi.org/10.1038/s41598-023-30909-0
- License Information
-
More Information
Article History
Received: 29 October 2022
Accepted: 3 March 2023
First Online: 30 March 2023
Competing interests
: LMS, EGS, EVP, LB, MW, ML, PSH and CAE are employees of Cincinnati Children’s Hospital Medical Center. SA, JT, KM, MH, PH, and KW are employees and shareholders of Scioto Biosciences.
